KORU Medical Systems Inc.

10/03/2023 | Press release | Distributed by Public on 10/03/2023 14:05

Statement of Changes in Beneficial Ownership - Form 4

FORM 4
Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287Expires:January 31, 2005Estimated average burden hours per response...0.5
1. Name and Address of Reporting Person *
Manko Joseph M. Jr.
2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [KRMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
1717 ARCH STREET , 37TH FLOOR
3. Date of Earliest Transaction (Month/Day/Year)
(Street)
PHILADELPHIA PA 19103
4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Join/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code 4. Securities Acquired (A) or Disposed of (D) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) 6. Ownership Form: Direct (D) or Indirect (I) 7. Nature of Indirect Beneficial Ownership
Code V Amount (A) or (D) Price
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code 5. Number of Derivative Securities Acquired (A) or Disposed of (D) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security 8. Price of Derivative Security 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) 11. Nature of Indirect Beneficial Ownership
Code V (A) (D) Date Exercisable Expriation Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Manko Joseph M. Jr.
1717 ARCH STREET
37TH FLOOR
PHILADELPHIA, PA19103 		X X
Horton Capital Management, LLC
1717 ARCH STREET
37TH FLOOR
PHILADELPHIA, PA19103
X
Horton Capital Partners, LLC
1717 ARCH STREET
37TH FLOOR
PHILADELPHIA, PA19103
X
Horton Capital Partners Fund, L.P.
1717 ARCH STREET
37TH FLOOR
PHILADELPHIA, PA19103
X
Horton Freedom, L.P.
1717 ARCH STREET
37TH FLOOR
PHILADELPHIA, PA19103


Less than 10% Owner

Signatures

/s/ Joseph M. Manko, Jr. 2023-10-03
**Signature of Reporting Person Date
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC 2023-10-03
**Signature of Reporting Person Date
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC 2023-10-03
**Signature of Reporting Person Date
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP 2023-10-03
**Signature of Reporting Person Date
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Freedom, L.P. 2023-10-03
**Signature of Reporting Person Date

Explanation of Responses:

(*) If the form is filed by more than one reporting person, see Instruction 5(b)(v).
(**) Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) See Exhibit 99.1 to this Form 4 for explanation of note (1).
(2) See Exhibit 99.1 to this Form 4 for explanation of note (2).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.